CapeStart Honored as a Winner in the 2025 Artificial Intelligence Excellence Awards

MadeAi™, CapeStart’s GenAI-Enabled Platform for the Life Sciences, wins in the Generative AI category,
helping organizations better compete and win in the AI Economy 

CAMBRIDGE, MA March 25, 2025—CapeStart, an industry leader in AI services and solutions, has been named a winner in the 2025 Artificial Intelligence Excellence Awards, presented by the Business Intelligence Group. The award honors MadeAi™, CapeStart’s GenAI-enabled, life science platform, in the Generative AI category—a platform that serves as the foundation for CapeStart’s AI solutions including MadeAi-LR, supporting systematic literature review (SLR). This win reflects CapeStart’s commitment to innovation, recognizing the company’s contributions to advancing AI in life sciences, and is the third such acknowledgment of MadeAi’s excellence in the past year. 

Built in partnership with top 20 pharmaceutical manufacturers, the MadeAi platform applies GenAI to time-consuming life science content synthesis processes, while maintaining essential human oversight for high accuracy, transparency, and traceability. MadeAi frees up life science professionals so they can focus on higher tasks. It helps to improve research quality, streamline information synthesis, and ultimately, expedite health technology commercialization for better patient outcomes.

With a single literature review requiring hundreds of hours, MadeAi-LR is helping teams save time, optimize resources, and scale research to drive innovation. By using GenAI, MadeAi-LR reduces literature review time by nearly half, with more than 90% accuracy. Its framework ensures compliance with FDA and EMA submission requirements, harnessing almost a decade of CapeStart’s AI expertise, clinical understanding, and custom consulting experience. Supported by a human-in-the-loop (HITL) approach that enhances AI innovation, MadeAi-LR turns a burdensome task into a streamlined, highly accurate source of added productivity. Other MadeAi platform offerings for global value dossiers, clinical content generation, and pharmacovigilance are currently in development.

“We are incredibly honored to receive this recognition from the Business Intelligence Group," said Gaugarin (“G”) Oliver, CEO and founder of CapeStart. "PhD researchers and highly credentialed experts should spend time on achieving breakthroughs in health, not conducting mundane tasks that can be offloaded at high accuracy to the right technology. This award is a testament to CapeStart’s mission, pushing the boundaries of AI to create solutions that improve productivity and help improve lives."
The Artificial Intelligence Excellence Awards celebrate the most innovative companies, technologies, and professionals leading the way in AI innovation. Winners are selected by a panel of industry experts who evaluate nominees based on their creativity, impact, and measurable success in AI-driven solutions. 

"The AI industry is evolving rapidly, and it is through the efforts of companies like CapeStart that we see real-world applications driving change," said Russ Fordyce, CEO of the Business Intelligence Group. "Their work exemplifies the kind of innovation and leadership that is shaping the future of artificial intelligence." 

For more information about CapeStart and its award-winning AI solutions, visit www.capestart.com. 

About Business Intelligence Group

The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization's proprietary and unique scoring system selectively measures performance across multiple business domains and rewards those companies whose achievements stand above those of their peers. For more visit www.bintelligence.com. 

About CapeStart

CapeStart helps organizations compete and win in the AI economy. Its AI solutions, including a GenAI-enabled life science platform, bring the efficiency of AI to life science firms while maintaining essential human oversight. CapeStart’s skilled data experts and software developers provide complex data annotation, ML and AI model development, and software development services to healthcare, finance, and retail companies, among others. Based in Cambridge, MA, CapeStart serves 100+ clients with 600+ resources across North America, the Middle East, and Asia. For more visit www.capestart.com.

Media Contacts:

Eliana Starbird
Chief Nominations Officer
Business Intelligence Group
contact@bintelligence.com
+1 909-529-2737

Meghan Oates-Zalesky       
Chief Marketing Officer for CapeStart
Meghan.Oates@capestart.com
617-435-2470       

Mary Kae Marinac     
PR Representative for CapeStart  
mk@mkmarinac.com       
978-685-3136